| Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery (NCT03117855) | City of Hope Medical Center | 2016-12-01 |
| Lenvatinib and Capecitabine in Patients With Advanced Malignancies (NCT02915172) | M.D. Anderson Cancer Center | 2016-12-01 |
| Ustekinumab for the Treatment of Giant Cell Arteritis (NCT02955147) | Massachusetts General Hospital | 2016-12-01 |
| A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis (NCT02977533) | Sanofi | 2016-12-01 |
| High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma (NCT03007823) | Fuda Cancer Hospital, Guangzhou | 2016-12-01 |
| Estradiol and Fear Extinction in Anorexia Nervosa (AN) (NCT02792153) | Johns Hopkins University | 2016-12-01 |
| Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects (NCT03007810) | Tianjin Hemay Bio-Tech Co., Ltd | 2016-12-01 |
| A Study to Assess the Efficacy and Safety of ABTL0812 (NCT03366480) | Ability Pharmaceuticals SL | 2016-12-01 |
| Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies (NCT02620839) | Pamela Munster | 2016-12-01 |
| A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis (NCT02965053) | Chugai Pharmaceutical | 2016-12-01 |
| Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT02728050) | University of Washington | 2016-12-01 |
| Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma (NCT02855450) | Dompé Farmaceutici S.p.A | 2016-12-01 |
| Adipose-derived Stem Cells to Treat Chronic Wounds. (NCT05797688) | Winthrop University Hospital | 2016-12-01 |
| Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection (NCT03001739) | Sir Run Run Shaw Hospital | 2016-12-01 |
| Denosumab for Prevention of Bone Complications After Bone Marrow Transplantation in Children (NCT02677246) | St. Justine's Hospital | 2016-12-01 |
| A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer (NCT03035253) | OncoMed Pharmaceuticals, Inc. | 2016-12-01 |
| KJ-TFC-004 Drug-drug Interaction Study (NCT02967614) | Kukje Pharma | 2016-12-01 |
| Risk Stratification of Heart Failure in Cardiomyopathies. (NCT02941315) | RenJi Hospital | 2016-12-01 |
| High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer (NCT03007875) | Fuda Cancer Hospital, Guangzhou | 2016-12-01 |
| A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma (NCT02954796) | Seagen Inc. | 2016-12-01 |
| Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence (NCT03015246) | Wayne State University | 2016-12-01 |
| Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer (NCT03008343) | Fuda Cancer Hospital, Guangzhou | 2016-12-01 |
| Safety Study of Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid (NCT02698813) | South China Research Center for Stem Cell and Regenerative Medicine | 2016-12-01 |
| Single Ascending Dose Study of Safety and Tolerability of SPH3127 Tablet in Chinese Healthy Volunteers (NCT03128138) | Shanghai Pharmaceuticals Holding Co., Ltd | 2016-12-01 |
| A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer (NCT03030287) | OncoMed Pharmaceuticals, Inc. | 2016-12-01 |
| The Feasibility and Safety of Instruments in Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer (NCT02943694) | Ruijin Hospital | 2016-12-01 |
| Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment (NCT01627795) | Oshadi Drug Administration | 2016-12-01 |
| Sildenafil for DCI (NCT03028298) | University of Mississippi Medical Center | 2016-12-01 |
| A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer (NCT02840994) | Bavarian Nordic | 2016-12-01 |
| Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma (NCT02743975) | University Medical Center Groningen | 2016-12-01 |
| Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD (NCT02561520) | Ladan Espandar | 2016-12-01 |
| Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance (NCT03025841) | Poitiers University Hospital | 2016-12-01 |
| Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy (NCT02324998) | Cambridge University Hospitals NHS Foundation Trust | 2016-12-01 |
| A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj. (NCT03076957) | Chong Kun Dang Pharmaceutical | 2016-12-01 |
| A Study of LY2775240 in Healthy Participants (NCT02963779) | Eli Lilly and Company | 2016-12-01 |
| An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates (NCT02929264) | Abide Therapeutics | 2016-12-01 |
| HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors (NCT02557854) | Theodore Laetsch | 2016-12-01 |
| Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer (NCT02885974) | Baylor College of Medicine | 2016-12-01 |
| Vasoconstriction Trial With LEO 90100 Aerosol Foam (NCT02973776) | LEO Pharma | 2016-12-01 |
| Evaluation of ATx201 as a Topical Antibiotic Agent (NCT03009734) | UNION therapeutics | 2016-12-01 |
| The Haem and Nitrite Study - The Effects of Haemoglobin NO-blockade on Nitrite-induced Forearm Vessel Dilatation (NCT03077763) | University of East Anglia | 2016-12-01 |
| A Phase 1 Drug Drug Interaction Clinical Trial of C1-R215 and C2-R215 in Healthy Male Volunteers (NCT03005340) | Alvogen Korea | 2016-12-01 |
| A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications (NCT03018405) | Celyad Oncology SA | 2016-12-01 |
| Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants (NCT02984852) | Janssen Scientific Affairs, LLC | 2016-12-01 |
| Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (NCT02981082) | Robert Lafyatis | 2016-12-01 |
| A Phase I Study of Quadrivalent HPV Recombinant Vaccine (NCT03085381) | Shanghai Bovax Biotechnology Co., Ltd. | 2016-12-01 |
| A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02711956) | Zenith Epigenetics | 2016-12-01 |
| High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer (NCT03008304) | Fuda Cancer Hospital, Guangzhou | 2016-12-01 |
| a Study of JY09 in Chinese Healthy Subjects (NCT02971722) | Beijing Dongfang Biotech Co., Ltd. | 2016-12-01 |
| Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis (NCT02965781) | Squarex, LLC | 2016-12-01 |
| PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer (NCT02985801) | Massimo Raimondo, M.D. | 2016-12-01 |
| Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic Conditions (NCT03051711) | Global Blood Therapeutics | 2016-12-01 |
| Fecal Microbiota Transplantation (FMT) for Severe Acute Pancreatitis(SAP) (NCT03015467) | First Affiliated Hospital of Chengdu Medical College | 2016-12-01 |
| A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS) (NCT03030612) | OncoVerity, Inc. | 2016-12-01 |
| Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole (NCT02998437) | Il-Yang Pharm. Co., Ltd. | 2016-12-01 |
| Phase I RVC With Ocriplasmin for CRVO (NCT02747030) | Universitaire Ziekenhuizen KU Leuven | 2016-12-01 |
| Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2) (NCT02971202) | Vanderbilt University | 2016-12-01 |
| FMT for MDRO Colonization After Infection in Renal Transplant Recipients (NCT02922816) | Emory University | 2016-12-01 |
| Adoptive Therapy Using Antigen-Specific CD4 T-Cells (NCT02210104) | M.D. Anderson Cancer Center | 2016-12-01 |
| High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer (NCT03008330) | Fuda Cancer Hospital, Guangzhou | 2016-12-01 |
| High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer (NCT03007836) | Fuda Cancer Hospital, Guangzhou | 2016-12-01 |
| Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects (NCT03018509) | Akros Pharma Inc. | 2016-12-01 |
| A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma (NCT02998047) | Actinium Pharmaceuticals | 2016-12-01 |
| Mesenchymal Stromal Cells for Ischemic Stroke (NCT01922908) | Sean Savitz | 2016-12-01 |
| A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies (NCT02978482) | AstraZeneca | 2016-12-01 |
| Safety, Tolerability and Pharmacokinetics of Simmiparib in Patients With Malignant Advanced Solid Tumor (NCT02993913) | Shanghai Acebright Pharmaceuticals Co., Ltd. | 2016-12-01 |
| Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis (NCT03337165) | Russian Academy of Medical Sciences | 2016-12-01 |
| TIL Therapy for Metastatic Renal Cell Carcinoma (NCT02926053) | Inge Marie Svane | 2016-12-01 |
| Safety Study of Afatinib for Brain Cancer (NCT02423525) | Santosh Kesari | 2016-12-01 |
| Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant (NCT02957656) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-12-01 |
| A Phase 1 Study Evaluating Safety and Efficacy of C-CAR011 Treatment in DLBCL Subjects (NCT02976857) | Shanghai AbelZeta Ltd. | 2016-12-01 |
| A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade (NCT03003676) | Targovax Oy | 2016-12-01 |
| The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo (NCT03247400) | Nicolaus Copernicus University | 2016-12-01 |
| Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients (NCT03120832) | Sensei Biotherapeutics, Inc. | 2016-12-01 |
| Phase 1 Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest (NCT02987088) | University of Washington | 2016-12-01 |
| Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC (NCT03042468) | Weill Medical College of Cornell University | 2016-12-01 |
| The Use of Self Inflating Tissue Expanders In The Treatment Of Alveolar Cleft (NCT03010345) | Cairo University | 2016-12-01 |
| Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease (NCT03008161) | Proclara Biosciences, Inc. | 2016-12-01 |
| HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma (NCT02947152) | Novartis Pharmaceuticals | 2016-12-01 |
| Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer (NCT02929862) | Lycera Corp. | 2016-12-01 |
| Single Dose Study of ANX005 in Healthy Volunteers (NCT03010046) | Annexon, Inc. | 2016-12-01 |
| Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors (NCT02982941) | MacroGenics | 2016-12-01 |
| A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter (NCT02988648) | Yale University | 2016-12-01 |
| IS-001 Injection Phase-1 Safety, Tolerance and Pharmacokinetics (NCT03006237) | Intuitive Surgical | 2016-12-01 |
| A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR741 in Healthy Volunteers (NCT03022175) | Spero Therapeutics | 2016-12-01 |
| New Formulation and Food Effect Study of BIIB074 (NCT02951221) | Biogen | 2016-12-01 |
| Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen (NCT02974361) | Oxford Pharmascience Ltd | 2016-12-01 |
| Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer (NCT02991196) | Daiichi Sankyo | 2016-12-01 |
| Safety and Pharmacokinetics of Multiple Dose of YC-6 in Healthy Subjects (NCT03358901) | Guangzhou Cellprotek Pharmaceutical Co., Ltd. | 2016-12-01 |
| The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC (NCT02915432) | Shanghai Junshi Bioscience Co., Ltd. | 2016-12-01 |
| Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism (NCT02999399) | Masonic Cancer Center, University of Minnesota | 2016-12-01 |
| PK Study of EXPAREL in Subjects Undergoing Open Spinal Fusion or Reconstructive Surgery (NCT02985762) | Pacira Pharmaceuticals, Inc | 2016-12-01 |
| High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer (NCT03008499) | Fuda Cancer Hospital, Guangzhou | 2016-12-01 |
| A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours (NCT03009214) | amcure GmbH | 2016-12-01 |
| Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury (NCT02917291) | Ferrer Internacional S.A. | 2016-12-01 |
| A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers (NCT02797795) | Neovia Oncology Ltd. | 2016-12-01 |
| Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease (NCT02952131) | Healeon Medical Inc | 2016-11-30 |
| Personalized DC Vaccine for Lung Cancer (NCT02956551) | Sichuan University | 2016-11-30 |
| Status Migrainosus - Differentiating Between Responders and Non-responders (NCT03066544) | Hartford HealthCare | 2016-11-30 |
| A Study Evaluating Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 and Etomidate for Induction of Anesthesia in Healthy Male Subjects (NCT04054063) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2016-11-30 |